Diffuse Large B-Cell Lymphoma

被引：729

作者：

Sehn, Laurie H. ^{[1
,2
]}

Salles, Gilles ^{[3
]}

机构：

[1] BC Canc Ctr Lymphoid Canc, 600 W 10th Ave, Vancouver, BC V5Z 4E6, Canada

[2] Univ British Columbia, Vancouver, BC, Canada

[3] Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2021年 / 384卷 / 09期

关键词：

RITUXIMAB PLUS CYCLOPHOSPHAMIDE; NON-HODGKIN-LYMPHOMA; PHASE-III TRIAL; ELDERLY-PATIENTS; RESPONSE ASSESSMENT; SINGLE-ARM; OPEN-LABEL; R-CHOP; CYCLES; MULTICENTER;

D O I：

10.1056/NEJMra2027612

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：842 / 858

页数：17

共 88 条

[41] Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial [J].

Locke, Frederick L. ;

Ghobadi, Armin ;

Jacobson, Caron A. ;

Miklos, David B. ;

Lekakis, Lazaros J. ;

Oluwole, Olalekan O. ;

Lin, Yi ;

Braunschweig, Ira ;

Hill, Brian T. ;

Timmerman, John M. ;

Deol, Abhinav ;

Reagan, Patrick M. ;

Stiff, Patrick ;

Flinn, Ian W. ;

Farooq, Umar ;

Goy, Andre ;

McSweeney, Peter A. ;

Munoz, Javier ;

Siddiqi, Tanya ;

Chavez, Julio C. ;

Herrera, Alex F. ;

Bartlett, Nancy L. ;

Wiezorek, Jeffrey S. ;

Navale, Lynn ;

Xue, Allen ;

Jiang, Yizhou ;

Bot, Adrian ;

Rossi, John M. ;

Kim, Jenny J. ;

Go, William Y. ;

Neelapu, Sattva S. .

LANCET ONCOLOGY, 2019, 20 (01) :31-42

[42] Diagnosis-to-Treatment Interval Is an Important Clinical Factor in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Has Implication for Bias in Clinical Trials [J].

Maurer, Matthew J. ;

Ghesquieres, Herve ;

Link, Brian K. ;

Jais, Jean-Philippe ;

Habermann, Thomas M. ;

Thompson, Carrie A. ;

Haioun, Corinne ;

Allmer, Cristine ;

Johnston, Patrick B. ;

Delarue, Richard ;

Micallef, Ivana N. ;

Peyrade, Frederic ;

Inwards, David J. ;

Ketterer, Nicolas ;

Farooq, Umar ;

Fitoussi, Olivier ;

Macon, William R. ;

Molina, Thierry J. ;

Syrbu, Sergei ;

Feldman, Andrew L. ;

Slager, Susan L. ;

Weiner, George J. ;

Ansell, Stephen M. ;

Cerhan, James R. ;

Salles, Gilles A. ;

Witzig, Thomas E. ;

Tilly, Herve ;

Nowakowski, Grzegorz S. .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (16) :1603-+

[43] Event-Free Survival at 24 Months Is a Robust End Point for Disease-Related Outcome in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy [J].

Maurer, Matthew J. ;

Ghesquieres, Herve ;

Jais, Jean-Philippe ;

Witzig, Thomas E. ;

Haioun, Corinne ;

Thompson, Carrie A. ;

Delarue, Richard ;

Micallef, Ivana N. ;

Peyrade, Frederic ;

Macon, William R. ;

Molina, Thierry Jo ;

Ketterer, Nicolas ;

Syrbu, Sergei I. ;

Fitoussi, Olivier ;

Kurtin, Paul J. ;

Allmer, Cristine ;

Nicolas-Virelizier, Emmanuelle ;

Slager, Susan L. ;

Habermann, Thomas M. ;

Link, Brian K. ;

Salles, Gilles ;

Tilly, Herve ;

Cerhan, James R. .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (10) :1066-1073

[44] Immunohistochemical Methods for Predicting Cell of Origin and Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab [J].

Meyer, Paul N. ;

Fu, Kai ;

Greiner, Timothy C. ;

Smith, Lynette M. ;

Delabie, Jan ;

Gascoyne, Randy D. ;

Ott, German ;

Rosenwald, Andreas ;

Braziel, Rita M. ;

Campo, Elias ;

Vose, Julie M. ;

Lenz, Georg ;

Staudt, Louis M. ;

Chan, Wing C. ;

Weisenburger, Dennis D. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (02) :200-207

[45] Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate-and high-grade non-Hodgkin's lymphoma [J].

Miller, TP ;

Dahlberg, S ;

Cassady, JR ;

Adelstein, DJ ;

Spier, CM ;

Grogan, TM ;

LeBlanc, M ;

Carlin, S ;

Chase, E ;

Fisher, RI .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (01) :21-26

[46]

Moccia A A., Blood advances

[47] Rituximab plus gemcitabine and oxaliplatin in patients with refractory/relapsed diffuse large B-cell lymphoma who are not candidates for high-dose therapy. A phase II Lymphoma Study Association trial [J].

Mounier, Nicolas ;

El Gnaoui, Taoufik ;

Tilly, Herve ;

Canioni, Daniele ;

Sebban, Catherine ;

Casasnovas, Rene-Olivier ;

Delarue, Richard ;

Sonet, Anne ;

Beaussart, Pauline ;

Petrella, Tony ;

Castaigne, Sylvie ;

Bologna, Serge ;

Salles, Gilles ;

Rahmouni, Alain ;

Gaulard, Philippe ;

Haioun, Corinne .

HAEMATOLOGICA, 2013, 98 (11) :1726-1731

[48] Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma [J].

Neelapu, S. S. ;

Locke, F. L. ;

Bartlett, N. L. ;

Lekakis, L. J. ;

Miklos, D. B. ;

Jacobson, C. A. ;

Braunschweig, I. ;

Oluwole, O. O. ;

Siddiqi, T. ;

Lin, Y. ;

Timmerman, J. M. ;

Stiff, P. J. ;

Friedberg, J. W. ;

Flinn, I. W. ;

Goy, A. ;

Hill, B. T. ;

Smith, M. R. ;

Deol, A. ;

Farooq, U. ;

McSweeney, P. ;

Munoz, J. ;

Avivi, I. ;

Castro, J. E. ;

Westin, J. R. ;

Chavez, J. C. ;

Ghobadi, A. ;

Komanduri, K. V. ;

Levy, R. ;

Jacobsen, E. D. ;

Witzig, T. E. ;

Reagan, P. ;

Bot, A. ;

Rossi, J. ;

Navale, L. ;

Jiang, Y. ;

Aycock, J. ;

Elias, M. ;

Chang, D. ;

Wiezorek, J. ;

Go, W. Y. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (26) :2531-2544

[49]

Nowakowski GS, J CLIN ONCOL

[50]

Nowakowski GS, 2021, J CLIN ONCOL

← 1 2 3 4 5 6 7 8 9 →